Chordia Therapeutics (TSE:190A) Ending Cash Position : 円0.00 Mil (As of Feb. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics Ending Cash Position?

Chordia Therapeutics's Ending Cash Position for the quarter that ended in Feb. 2025 was 円0.00 Mil.

Chordia Therapeutics's annual Ending Cash Position increased from Aug. 2022 (円4,254.96 Mil) to Aug. 2023 (円4,799.04 Mil) but then declined from Aug. 2023 (円4,799.04 Mil) to Aug. 2024 (円4,329.62 Mil).

Chordia Therapeutics Ending Cash Position Historical Data

The historical data trend for Chordia Therapeutics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics Ending Cash Position Chart

Chordia Therapeutics Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

Ending Cash Position

1,998.15

4,254.96

4,799.04

4,329.62

Chordia Therapeutics Quarterly Data
	Aug21	Aug22	May23	Aug23	May24	Aug24	Feb25
Ending Cash Position	Get a 7-Day Free Trial			-	-	-	-	-

Chordia Therapeutics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Chordia Therapeutics's Ending Cash Position for the fiscal year that ended in Aug. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	4799.034	+	-469.41
	=	4,329.62

Chordia Therapeutics's Ending Cash Position for the quarter that ended in Feb. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

Chordia Therapeutics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012

Website

https://www.chordiatherapeutics.com

Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines